A controlled endoscopic study comparing the toxic effects of sulindac, naproxen, aspirin, and placebo on the gastric mucosa of health volunteers.
Sixty volunteers were endoscopically evaluated to compare gastric mucosal injury following oral administration of sulindac, naproxen, aspirin, or placebo for two consecutive seven-day periods. A single-blind technique was utilized wherein the endoscopist was unaware which drug each volunteer had received. The following dosages were employed for the two study periods: sulindac, 150 and 200 mg, b.i.d., naproxen, 250 and 375 mg, b.i.d., and aspirin, 650 and 975 mg, q.i.d. The only subject who developed a frank ulcer with mucosal bleeding was in the sulindac group, however volunteers taking sulindac demonstrated statistically less significant mucosal injury on endoscopic examination than those receiving naproxen or aspirin.
D000328:Adult; D001241:Aspirin / Q000009:adverse effects* / Q000097:blood; D005260:Female; D005753:Gastric Mucosa / Q000187:drug effects*; D005773:Gastroscopy; D006801:Humans; D007192:Indenes / Q000009:adverse effects*; D008297:Male; D009288:Naproxen / Q000009:adverse effects* / Q000097:blood; D010919:Placebos; D013276:Stomach Ulcer / Q000139:chemically induced; D013467:Sulindac / Q000009:adverse effects* / Q000097:blood
D007192:Indenes; D010919:Placebos; D013467:Sulindac; D009288:Naproxen; D001241:Aspirin